Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients
DC Chan, SJ Hamilton, KA Rye, GT Chew, AJ Jenkins, G Lambert, GF Watts
Diabetes Obesity & Metabolism | WILEY-BLACKWELL | Published : 2010
Awarded by NHF
D.C. Chan is a Career Development Fellow of the National Health and Medical Research Council (NHMRC). S. J. Hamilton received a postgraduate scholarship from the NHMRC. This work was also supported by an NHF grant in aid G08S3700 to G. Lambert and K. A. Rye. Wethank Solvay for supplying the fenofibrate and matching placebo for the study.